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Iron dysregulation has been linked to a variety of human diseases, such as anemia, 
Friedreich’s ataxia, X-linked sideroblastic anemia, sideroblastic-like microcytic anemia, 
and myopathy. Thus, it is vitally important to understand the mechanisms for regulating 
intracellular iron. Here, we use fluorescence microscopy techniques in live cells to study 
interactions of the yeast proteins Grx3/4, Aft1/2, and Bol2, which have been shown to be 
involved in turning off iron import when the cell has adequate iron. Modified versions of 
genes encoding these proteins have been incorporated into several yeast backgrounds to 
use fluorescence to monitor interactions under varying iron levels. 
 
ABSTRACT 
Iron metabolism disorders are the most common nutritional disorders in the 
world. Because iron is integral in many cellular processes, such as oxygen transport in 
blood and energy production in mitochondria, it is vital that adequate iron levels are 
maintained in the body. As a result, understanding the mechanism of iron regulation is 
critical to preventing and treating iron metabolism disorders. To better characterize iron 
regulation at the cellular and molecular level, we use Saccharomyces cerevisiae, or 
bakers’ yeast, as a model system.  In S. cerevisiae, expression of iron uptake and import 
genes is promoted by the paralogous transcription factors Aft1 and Aft2 which shuttle 
between the nucleus and cytosol in an iron-dependent mechanism. It is hypothesized that, 
in iron replete conditions, the monothiol glutaredoxins Grx3 and Grx4, and the BolA-like 
protein Bol2 interact to form a [2Fe-2S] cluster bound heterodimer. This complex is 
proposed to transfer a [2Fe-2S] cluster to Aft1/2 promoting their dimerization and 
translocation into the cytosol, thereby turning off expression of iron uptake and storage 
systems. Grx3/4 have been shown to interact with Aft1/2 in vivo, but no definite role has 
been shown for Bol2 in this interaction. To investigate whether Bol2 is required for the 
interaction between Aft1/2 and Grx3/4, each protein is fused with either the C-terminal 
half (VC) or the N-terminal half (VN) of the yellow fluorescence protein Venus.  
Bimolecular fluorescence complementation (BiFC) studies will be performed to 
determine whether Grx3/4 interact with Aft1/2 in the absence and presence of Bol2. 
Interactions will be monitored in cells grown under varying iron concentrations via 
fluorescence microscopy and flow cytometry. We have successfully cloned the genes for 
VN-tagged versions of Grx3 (VN-Grx3) and VC-tagged Aft1/2 (Aft1-myc-VC and myc-
Aft2-VC) into vectors that allow for doxycycline-controlled (TetOFF) expression and 
transformed them into various S. cerevisiae strains. Furthermore, we have confirmed the 
expression of VN-Grx3 with western blot, and the expression of Aft1/2-VC via growth 
rescue on plates. Since both Grx3/4 and Bol2 have close human homologs, these studies 




Iron is an essential micronutrient 
that plays a vital role as a redox cofactor in 
many cellular processes such as 
respiration, translation, DNA replication 
and repair, and oxygen transport. 
However, in excess iron conditions, the 
same properties that make it so vital can 
lead to the production of reactive oxygen 
species (ROS) that damage nucleic acids, 
proteins, and lipids in the cell and can lead 
to organ damage in humans as a result of 
oxidative stress.1 For that reason, cell 
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survival depends on maintaining optimal 
iron levels via complex mechanisms 
including balanced intracellular 
distribution between cellular 
compartments and strict control of iron 
uptake. Loss of this control, leading to 
abnormally high or low levels of 
intracellular iron, can cause either iron 
overload or iron deficiency. Iron 
dysregulation has been linked with human 
diseases such as anemia, which is the most 
common nutritional disorder in the world2, 
Friedreich’s ataxia, X-linked sideroblastic 
anemia, sideroblastic-like microcytic 
anemia, and myopathy.3,4 Due to these 
health concerns, understanding the 
mechanisms for maintaining iron 
homeostasis is an important field of 
current research. 
Brewer’s yeast, Saccharomyces 
cerevisiae, is a common model organism 
for studying iron regulation and transport 
due to its ease of genetic manipulation and 
the evolutionary conservation of pathways 
for iron uptake, distribution, and iron 
cofactor biosynthesis.5,6 Mechanistic 
insight provided by yeast studies has led to 
greater understanding of human diseases, 
including iron-related diseases such as 
Friedreich’s ataxia and 
aceruloplaminemia.7-9 Yeast iron import 
and uptake is regulated in the nucleus by 
the paralogous transcription factors Aft1 
and Aft2, which activate several genes 
involved in iron uptake, transport, and 
storage (known as the iron regulon) under 
iron deplete conditions. However, under 
iron replete conditions, Aft1/2 are found as 
dimers in the cytosol indicating that the 
transcription factors are exported from the 
nucleus when adequate iron is present in 
the cell.10-12 Although Aft1/2 are paralogs, 
Aft1 is considered the primary 
transcription factor because aft1∆ strains 
show a more severe growth phenotype 
than aft2Δ strains in iron-deficient 
conditions.13,14 The monothiol 
glutaredoxins Grx3 and Grx4 have been 
shown to influence Aft1/2 activity in iron 
homeostasis. Deletion of GRX3 or GRX4 
shows no phenotype but the double 
deletion causes iron overaccumulation 
from continuous activation of the iron 
regulon. They are therefore believed to be 
redundant and involved in removing 
Aft1/2 from the DNA.15-17 
Investigation of this Grx3/4-Aft1/2 
relationship led to identification of the 
BolA-like protein Bol2 (previously Fra2) 
as part of an iron signaling complex that 
sends an inhibitory signal to Aft1/2 under 
iron replete conditions.18 As a 
consequence, Aft1/2 are proposed to 
dimerize and be exported from the nucleus 
to the cytosol via the exportin Msn5.18,19 
Restriction of Grx4 to the cytosol did not 
show an effect on Aft1/2 inhibition, so it is 
believed that the Grx3/4-Bol2 complex 
operates in the cytosol.18 Our group 
previously demonstrated that Grx3 and 
Bol2 form a [2Fe-2S]-bridged heterodimer 
that transfers a [2Fe-2S] cluster to Aft2, 
which drives Aft2 dimerization and 
decreases its affinity for DNA. Although 
Bol2 has been demonstrated to be required 
for this interaction in vitro,20 the same has 
not been shown in vivo. Bimolecular 
fluorescence complementation studies are 
a promising way to test this hypothesis. 
These studies involve tagging of 
two interacting proteins each with one half 
the yellow fluorescence protein (YFP) 
known as Venus. If the proteins interact, 
the two halves will come together to 
reform the complete fluorescent protein 
and generate a fluorescent signal 
detectable by microscopy or flow 
cytometry.21 To reduce the chance that the 
interaction between the target proteins 
hinders interaction between the two 
fluorescent protein halves, a flexible linker 
sequence is built between the target 
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protein and the YFP fragment to enable 
correct folding of each. Our research goal 
is to use bimolecular fluorescence 
complementation studies to test whether 
Bol2 in required for the Grx3/4 interaction 
with Aft1/2 in vivo. Furthermore, we are 
attempting to determine in which cellular 
compartment the interaction takes place 
using fluorescence microscopy of live 




All chemicals were purchased from 
Sigma, ThermoFisher, or otherwise 




Initially, AFT1-VC was integrated 
into the S. cerevisiae genome, and 
although PCR colony screening indicated 
the presence of AFT1-VC in place of the 
native AFT1 gene, Aft1-VC expression 
was not detectable using western blotting 
when probed with the YFP antibody. 
Consequently, the pCM189 yeast 
overexpression vector containing the 
TetOFF inducible promoter was used to 
clone Aft1 tagged with both a myc tag and 
the C-terminal half of Venus (VC) tag at 
the C-terminus of Aft1. The resulting 
plasmid was named pCM189-TetOFF-
Aft1-myc-linker-VC-LEU2 or pWR104. 
The LEU2 gene was used for selecting 
transformed cells when incorporated into 
yeast strains (see “Yeast Transformation” 
section). The TetOFF promoter is an 
overexpression promoter that can be 
turned off by the addition of doxycycline 
(doxy) and was used as a tool for 
controlling the protein expression. 
Attempts to integrate VN-GRX3 
into the S. cerevisiae genome were 
unsuccessful. Therefore, a gene encoding 
Grx3 missing the first 35 amino acids and 
tagged at the N-terminus with the N-YFP 
half of Venus (VN) was cloned into the 
pRS415 yeast overexpression vector, 
creating pRS415-VN-linker-Grx3(Δ1-35)-
LEU2 or pWR101. In this construct, Grx3 
protein expression was under the control 
of the native GRX3 promoter and started 
from the second start codon. The LEU2 
gene was used to select for the yeast cells 
transformed with the pWR101 plasmid. 
However, VN-linker-Grx3 expression was 
very low, almost nonexistent, as visualized 
by western blotting because the native 
promoter seems to require the sequence 
between the first and second start codons 
(Caryn Outten lab, unpublished data). A 
new plasmid, pRS415-VN-linker-Grx3-
LEU2 or pWR102, containing VN-tagged 
full length Grx3 in the pRS415 vector and 
expressed under the native promoter was 
then created. However, there was little to 
no improvement in the VN-linker-Grx3 
expression when the plasmid was  
transformed into yeast cells. To 
improve the expression levels of VN-
linker-Grx3, the native GRX3 promoter in 
pWR102 was replaced with the 
constitutive PGK1 promoter and the new 
plasmid was named pRS415-
PGK1promoter-VN-linker-Grx3(Δ1-35)-
LEU2, or pAA120. Finally, VN-linker-
Grx3 was cloned into the pCM189 yeast 
overexpression vector containing the 
TetOFF doxycycline-repressible promoter, 
the new plasmid was named pCM189-
TetOFF-VN-linker-Grx3-URA3, or 
pWR103. 
Aft2 was tagged at the N-terminus 
with one myc tag for immunoblot 
detection purposes and with the VC tag at 
the C-terminus. The tagged gene was then 
inserted into the pCM189-TetOFF-LEU2 
backbone vector and the resulting plasmid 
was called pCM189-TetOFF-myc-Aft2-
linker-VC-LEU2, or pWR105. 
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The pWR103, pWR104 and 
pWR105 plasmids were then transformed 
into yeast strains for subsequent use in 
BiFC studies. The detailed method for 
creating these plasmids is described 
below. 
Production of pWR103, pWR104, 
and pWR105 began with amplifying each 
target gene or tag from other plasmids (see 
below) using polymerase chain reaction 
(PCR) such as the reaction seen in Table 1 
and the primers listed in Table 2. The VN-
linker-Grx3 fragment required for 
pWR103 was amplified out of pAA120. 
The Aft1-myc and linker-VC fragments 
for pWR104 were amplified from pESC-
Aft1-myc (created in 2016 by summer 
high school student Wesley Leaphart in 
the Outten Lab and pCM189-TetOFF-
Fra2-VC18 (gift from Prof. Dennis Winge), 
respectively. The myc-Aft2 and linker-VC 
fragments for pWR105 were amplified 
from S. cerevisiae genomic DNA and the 
pCM189-TetOFF-Fra2-VC plasmid, 
respectively. In the myc-Aft2 PCR, the 
myc tag was built into the forward primer 
allowing Aft2 amplification from genomic 
Table 1: Example PCR for amplification of inserts used in plasmid production 
5 ng/μL DNA Template 1 μL 2 μL 4 μL 
5x Q5 Buffer 10 μL 10 μL 10 μL 
10 mM dNTPs 1 μL 1 μL 1 μL 
5 μM FW Primer 5 μL 5 μL 5 μL 
5 μM REV Primer 5 μL 5 μL 5 μL 
Q5 Enhancera 10 μL 10 μL 10 μL 
Q5 Polymerase (2000 
U/mL) 
0.5 μL 0.5 μL 0.5 μL 
Sterile ddH2O to 50 μL to 50 μL to 50 μL 
a Q5 Enhancer was only used for linker-VC and myc-Aft2 fragment amplifications because of their high 
G/C contents (≥65%).  
Table 2: PCR Primers used for amplification of inserts used in plasmid production 

















































a Restriction enzyme sequence included in the primer is shown in bold. 




DNA with the myc tag inserted at the N-
terminus (Table 2). 
These fragments were inserted into 
the plasmid backbones pCM189-TetOFF-
Grx4-VN for pWR103 and pCM189-
TetOFF-Fra2-VC18 for pWR104/pWR105. 
Both backbones were digested with 
BamHI and NotI to provide an open site 
for the fragments to insert during plasmid 
creation via Gibson Assembly (GA).22 For 
the GA reactions, each fragment and the 
backbone vector were mixed in solution 
with a GA master mix of enzymes (New 
England Biolabs) which assembled the 
final plasmid by combining the 
fragments/inserts and vector backbone 
during incubation at 50 °C. The GA 
vector:fragment/insert ratios and 
incubation times used during plasmid 
assembly are listed in Table 3. 
 
Plasmid Amplification and Verification 
 The GA reaction mixtures were 
mixed with 1x EZ Vision One DNA 
Loading Dye (Amresco), ran on 0.8% 
agarose gels and visualized using Gel 
DocTM EZ Imager (BIO-RAD). Digested 
backbone vectors and inserts were diluted 
to similar concentration as used in the GA 
reactions and loaded into the agarose gels 
as controls. The GA plasmids deemed 
potentially correct, based on the gel, were 
transformed into Escherichia coli DH5α 
chemically competent cells using a 
standard transformation protocol. The 
transformations were done in duplicate for 
each strain using 1 μL and 2 μL of the GA 
products. The transformed cells, along 
with a non-transformed control of DH5α, 
were then incubated overnight (16-18 
hours) on LB + 100 μg/mL Amp plates at 
37 °C. The amplified GA plasmid was 
then isolated using the Wizard® Plus 
Minipreps DNA Purification System 
(Promega) for the pWR103 plasmid and 
the ThermoScientific GeneJet Plasmid 
Miniprep kit for the pWR104 and 
pWR105 plasmids. The purified plasmids 
were subjected to restriction digestions to 
verify that the plasmids produced were the 
intended product. pWR103 was digested 
with HindIII and EcoRI-HF. pWR104 was 
digested with NdeI and HindIII. pWR105 
was digested with EcoRI-HF and NheI- 
Table 3: Gibson Assembly experimental set up  
Plasmid Ratio Incubation Time (min) 









50 ng : 100 ng : 100 ngb 
15 0.05 pmol : 0.1 pmol: 0.1 pmolb 
0.02 pmol : 0.1 pmol : 0.1 pmolb 
pWR105 
50 ng : 100 ng : 100 ngc 
15 
 
100 ng : 200 ng : 200 ngc 
0.05 pmol : 0.1 pmol : 0.25pmolc 
0.05 pmol : 0.1 pmol : 0.1 pmolc 
Table indicates ratios and incubation times used in separate GA reactions. For example, the pWR103 
reaction was carried out for the given ratio in two separate reactions with the specified times. Reactions 
under bolded conditions produced the successful GAs that were used in the next experimental steps. 
a vector : VN-linker-Grx3 
b vector : Aft1-myc : linker-VC 




HF. Samples that yielded the correct 
digestion pattern were confirmed by DNA 
sequencing (Genewiz) using the primers 
described (Table 4). 
pWR103/pWR104/pWR105 plasmids 
confirmed by DNA sequencing were then 
inserted in yeast strains via chemical 
transformations (see below). 
 
Yeast Transformation 
Deletion strains (grx3Δ, bol2Δ, 
aft1Δ and aft2Δ) from the BY4741 (MATa 
his3Δ1 leu2Δ0 met15Δ0 ura3Δ0) 
background were derived from the 
Saccharomyces Genome Deletion Project 
and purchased from Open Biosystems.  
Strains were plated on YPD plates and 
incubated anaerobically at 30 °C for 48-72 
hours. YPD liquid cultures (5-mL) were 
inoculated with a loopful of cells from 
each strain and grown for 4-5 hours at 30 
°C with shaking. The pWR103 and 
pWR104 plasmids were transformed into 
grx3Δ, bol2Δ, and aft1∆ strains. pWR105 
was transformed into grx3Δ and aft2Δ. 
The 5-mL cultures were centrifuged at 
3000 rpm for 5 minutes. The cells were 
resuspended in sterile, ultrapure H2O, 
transferred to a microcentrifuge tube, and 
centrifuged at 14000 rpm for 10 seconds. 
The supernatant was aspirated off and the 
cells were resuspended in 800 μL sterile 
ultrapure H2O, 100 μL of a pH 8 solution 
of 10 mM ethylenediaminetetraacetic acid 
(EDTA) + 100 mM Tris (10x TE 
solution), and 100 μL lithium acetate 
(LiAc) at pH 7.4. 10 mg/mL sonicated 
salmon sperm DNA was boiled for 10 
minutes at 98 °C. 
Transformations were prepared 
using 100 μL of the resuspended yeast 
cells, 10 μL boiled salmon sperm DNA, 
and either 5 μL of DNA or sterile, 
ultrapure H2O as a control. 500 μL of a 
36% poly(ethylene glycol) (PEG, MW 
3350), 100 mM LiAc, 1x TE solution was 
added to each transformation and mixed 
by inverting the microcentrifuge tube. The 
cells were then incubated at 30 °C for one 
hour. 5 μL DMSO was added to each and 
they were moved to 42 °C for 10 minutes. 
1 mL sterile, ultrapure H2O was added to 
each and they were moved to ice for 2 
minutes. Finally, the cells were spun down 
at 12000 rpm for 30 seconds and the 
supernatant was aspirated off. The cells 
were resuspended in 100 μL sterile, 
ultrapure H2O and plated on selective 
media (2% bacteriological agar, US 
Biological) for anaerobic growth at 30 °C 
for 48-72 hours. The selective media used 
for all steps involving pWR103 was 
synthetic complete lacking uracil (SC-
URA). Selective medias for pWR104 and 
pWR105 was synthetic complete lacking 
leucine (SC-LEU). For transformations in 
which both plasmids were inserted in the 
yeast cells, the selective media was 
Table 4: Primers used for plasmid confirmation by DNA sequencing (Genewiz) 
Plasmid Primer name Primer Sequence (5’ to 3’) 
 
pWR103 
FW pCM189_G4VN_FW GGGATGCATGTGCTCTGTATG 
FW 1_Grx3_VN/VC_scrn CAGTTGGGCAGAACCATGCAAAG 
REV 2_VN_screen GTGGTGCAGATCAGCTTCAG 
REV M13R Genewiz primer 
 
pWR104 
FW pCM189_G4VN_FW GGGATGCATGTGCTCTGTATG 
FW 1_Aft1_VN/VC_scrn CCAGTCCATCATGACCCAAATG 
REV 2_VC_screen GTGGTGCAGATCAGCTTCAG 
REV M13R Genewiz primer 
 
pWR105 
FW pCM189_G4VN_FW GGGATGCATGTGCTCTGTATG 
REV 2_VC_screen GTGGTGCAGATCAGCTTCAG 
REV M13R Genewiz primer 
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synthetic complete lacking both uracil and 
leucine (SC-LEU-URA).  
 
Yeast Transformation Confirmation 
The transformations were tested 
via repetitive selection, western blotting 
and/or spot tests (see below). 
Repetitive selection: The 
transformations were repeatedly grown 
anaerobically at 30 °C for 48-72 hours on 
corresponding 2% agar selective media to 
ensure that only cells containing the 
desired plasmid survive. Cell stocks of the 
transformed cells were prepared in 
selective media with 12-15% glycerol and 
stored at -80 °C. 
Western blotting: Initially, proteins 
were prepared for western blot following a 
protocol described in previous work.19 The 
cells from the glycerol stocks were plated 
on selection media, grown anaerobically 
for 48-72 hours at 30 °C, and then 
inoculated in 5-mL selective media 
cultures for 24 hours at 30 °C. These 
cultures were grown overnight, diluted 
1000x into fresh 5-mL selective media 
cultures supplemented with 1 μg/mL doxy, 
and grown for an additional 24 hours at 30 
°C. Fresh 50-mL selective media cultures 
were inoculated with the second overnight 
cultures to a 50x dilution and grown 24 
hours at 30 °C prior to lysing the cells and 
 
 
Figure 1. Growth methods used in preparation for Western blotting. A) The initial method of 
growing cells for western blot, which involved three steps of incubating selective media cultures 24 
hours at 30 °C while shaking. In the first step, a 5-mL selective media culture without doxy was 
inoculated with cells from a plate. After the first culture was incubated, the second selective media 
culture with 1 μg/mL doxy was inoculated with cells from the first at a 1000x dilution. After the second 
culture was incubated, the final 50-mL culture without doxy was inoculated with cells from the 
previous culture at a 50x dilution and incubated. B) The second method of growing cells for western 
blot, which involved two steps of incubating selective media cultures 24 hours at 30 °C while shaking. 
The initial 5-mL selective media culture with 1 μg/mL doxy was inoculated from plates, like the first 
growth method. After that culture grew, two 1000x dilutions were prepared in 50-mL cultures, one with 
and one without 1 μg/mL doxy. This growth method was designed so proteins from non-induced and 




extracting the proteins (Figure 1A).18 
Unfortunately, our tagged proteins were 
not detected on western blots. For this 
reason, another growth method in which 
cells were grown in 5-mL selection 
cultures supplemented with 1 μg/mL doxy 
for 24 hours at 30 °C before being 
inoculated into two 50-mL selection 
cultures (1000x dilutions) either with or 
without 1 μg/mL doxy (Figure 1B).23 
These cultures were then grown 24 hours 
at 30 °C and a whole cell yeast extraction 
with glass beads protocol was used to 
isolate total protein from the cell cultures. 
Because doxy inactivates TetOFF plasmid 
expression, this growth method produced 
cell lysates that contained our tagged 
proteins when doxy was absent (induced 
cells) and cell lysates that did not contain 
the desired proteins when doxy was 
present (non-induced cells). 
Bradford Assay was used to 
determine protein concentration for each 
whole cell extraction. Using this 
information, samples of 75 µg protein in 
20 µl + 4 µl 6x Laemmli buffer 
(www.easyprotocols.com/6x-laemmli-
buffer-sample-buffer-for-western-blot) 
were prepared for each transformation and 
run on Tris-glycine SDS-PAGE gels 
(Invitrogen by ThermoScientific). The 
proteins were transferred to nitrocellulose 
membranes (Amersham) as part of the 
standard western blot procedure and the 
membranes were incubated at room 
temperature with equal amounts PBS and 
Odyssey blocking buffer (LI-COR®) 
overnight. The next day, the membranes 
were incubated with the appropriate 
primary antibody, washed 4 times with 20 
mL PBS + 0.1% Tween (PBST), incubated 
with the appropriate secondary antibody, 
and washed 4 times with 20 mL PBST 
before visualization with the Odyssey 
Imaging System (LI-COR). Antibodies are 
listed in Table 5. 
Table 5: Antibodies used for western blotting of transformations for each plasmid 
 Primary 
Antibody 



























































































Spot testing: Spot tests were used 
for confirming the expression of pWR104 
and pWR105 plasmids in yeast cells, 
taking advantage of the reported limited 
growth exhibited by the aft1∆ and aft2Δ 
strains when grown under iron depleted 
conditions.13,14 To prepare for spot testing, 
transformed cells were grown 
anaerobically at 30 °C for 48-72 hours. 
These cells were used to inoculate a 5-mL 
culture of selective media + 100 μM iron 
chelator bathophenanthrolinedisulfonic 
(BPS) + 5 μg/mL doxy for Aft1-myc-VC 
and myc-Aft2-VC, which were grown 
overnight at 30 °C with shaking. The cells 
were serially diluted to prepare solutions 
of OD 2.0, 0.2 and 0.02. 3 μL of each 
dilution was plated (Figure 2) on various 
selective media as described in Table 6. 
These plates were then grown 48-144 
hours depending on how sickly the cells 




Cloning of VN-linker-Grx3, Aft1-myc-
linker-VC, and myc-Aft2-linker-VC 
Containing Plasmids 
After each GA attempt, the 
products were run on agarose gels to 
visualize and evaluate whether they were 
successful. For the VN-Grx3 gel, the size 
difference between the expected GA 
product (9647 bp) and the digested 
pCM189-TetOFF-Grx4-VN vector 
backbone (9675 bp) was too small to see 
the difference on the gel (Figure 3A). 
However, the GA product for Aft1-myc-
 
Table 6: Growth media used for testing the expression of Aft1-myc-VC and myc-Aft2-
linker-VC in various strains via spot testing 




100 μg/mL - - 
100 μg/mL - 2 μg/mL 
- 100 μg/mL - 
- 100 μg/mL 1 μg/mL 
Aft1-myc- 
linker-VC + VN- 
linker-Grx3 
SC-LEU/-URA 
100 μg/mL - - 
100 μg/mL - 2 μg/mL 
- 100 μg/mL - 




- - - 
- - 1 μg/mL 
100 μg/mL - - 
100 μg/mL - 2 μg/mL 
- 100 μg/mL - 
- 100 μg/mL 1 μg/mL 
 
Figure 2. Diagram of how spot testing dilutions 
were plated on selective media. The plate was 
split in half so two different sets of transformed 
cells could be tested per plate. Each row on both 
sides corresponds to a different colony for that set 
of transformation cells. Each column corresponds 
to the dilution plated at that position. OD 2.0, 0.2, 
and 0.002 dilutions corresponds to the left, 
middle, and right columns, respectively, on each 




VC (12424 bp) was much larger than the 
digested pCM189-TetOFF-Fra2-VC 
vector (10681 bp), so two bands can be 
seen (Figure 3B). The larger corresponds 
to the GA product while the smaller 
corresponds to leftover vector that the 
Aft1-myc and linker-VC fragments were 
not inserted into. There is also a faint 
second band above the leftover Aft1-myc 
insert in the GA lane which may represent 
where the Aft1-myc and linker-VC 
fragments were joined together but not 
inserted into the vector. The GA product 
and digested backbone vector were too 
close in size for myc-Aft2-linker-VC as 
well. However, the myc-Aft2 and linker-
VC fragments loaded next to the GA were 
identical quantities to the amounts loaded 
from the GA, making it easy to assess the 
amount of each consumed during the GA 
reaction for the assembly of the pWR105 
plasmid. Because the bands in the GA lane 
were slightly less intense, some of the 
PCR products loaded into the GA were 
likely taken up by the vector to form the 
myc-Aft2-linker-VC plasmid (Figure 3C). 
 
 
Figure 3. Gel electrophoresis for preliminary assessment of the GA products. A) GA for pWR103. 
DNA ladder (8 µg total DNA) was loaded in leftmost lane, followed by 5 µL GA mixture (9647 bp), 5 
µL VN-linker-Grx3 PCR insert (1346 bp), and 5 µL pCM189 digested vector (9675 bp). The vector is a 
similar size to the expected GA, so we cannot conclusively say whether the plasmid was produced 
based on the agarose gel results. The lower band corresponds to leftover VN-Grx3 fragment that was 
not incorporated into the vector backbone. B) GA for pWR104. 5 µL two GA mixtures (12424 bp) 
using different pmol ratios were loaded into the leftmost lanes, followed by 5 µL pCM189 digested 
vector (10681 bp), 5 µL Aft1-myc PCR insert (2152 bp), 5 µL linker-VC PCR insert (347 bp), and 
DNA ladder (8 µg total DNA). There appears to be a band corresponding to pWR104 above another 
corresponding to the digested vector. Beneath those bands, additional bands represent the leftover Aft1-
myc and linker-VC fragments that were not incorporated into the vector. C) GA for pWR105. 5 µL of 
linker-VC PCR insert (322 bp) was loaded into the leftmost lane, followed by 5 µL GA mixture (11605 
bp), 5 µL myc-Aft2 insert (1327 bp), and DNA ladder (8 µg total DNA). Beneath the band 




After the plasmids were amplified 
in E. coli DH5α competent cells and 
purified, restriction digests confirmed that 
the plasmids extracted from the colonies 
were the correct GA products (Figure 4). 
The restriction enzymes were chosen to 
produce patterns that differentiate between 
the vector and intended products by 
digesting at several locations, including 
 
 
Figure 4. Restriction digest for testing colonies. 20 µl restriction digestion reactions were incubated 
at 37 °C for 1 hour and loaded on a 0.8% agarose gel. A) pWR103 was digested with HindIII and 
EcoRI-HF. Only colony 2 looks like the correct plasmid. Colonies 3 and 5 resemble the vector’s 
digestion pattern. Colonies 1 and 4 look different from both. B) pWR104 was digested with NdeI and 
HindIII. All colonies look like the expected plasmid except colony 4, which looks like the vector. C) 
pWR105 was digested with EcoRI-HF and NheI-HF. Colonies 6 and 7 appear to be the correct plasmid. 
The other colonies, including the colonies not shown, look like the vector. The red boxes identify the 




inside the fragments that were inserted 
during the GA. 
Agarose gel of the pWR103 
plasmid digested with HindIII and EcoRI-
HF showed that only colony 2 contained 
the expected digest pattern (Figure 4A). 
Colonies 3 and 5 show the expected 
digestion pattern for pCM189-TetOFF-
Grx4-linker-VN backbone, which 
indicates that the PCR fragments were not 
incorporated for these samples. Colonies 1 
and 4 display unusual patterns that do not 
match patterns of either the vector 
backbone or the expected product. All 
colonies from the pWR104 plasmid 
digested with NdeI and HindIII appear to 
show the pattern for the expected plasmid 
except colony 4, which resembles the 
pCM189-TetOFF-Fra2-linker-VC vector 
digest (Figure 4B). Digests of the pWR105 
plasmid show that colonies 6 and 7 are the 
correct plasmid. The other colonies appear 
to be the pCM189-TetOFF-Fra2-linker-
VC backbone vector. DNA sequencing 
(Genewiz) of each colony identified as 
potentially correct verified these results. 
 
Yeast Transformations and 
Confirmation 
Repetitive Growth: Colony 2 of the 
VN-linker-Grx3 - containing plasmid, 
colony 1 of the Aft1-myc-linker-VC - 
containing plasmid, and colony 6 of the 
myc-Aft2-linker-VC - containing plasmid 
were transformed into the various yeast 
strains required for these experiments (see 
Methods). The transformations were tested 
by repeated plating on selective media as 
the plasmids contain genes that allow the 
yeast to survive under those conditions 
(Figure 5). Western blotting and spot tests 
were also performed to verify the plasmids 
were both present in the cells and the 
tagged proteins were expressed. 
Western blotting: The 
transformation of pWR103 into grx3Δ was 
determined to have failed as the western 
blots probed with α-Grx3 showed no 
expression for VN-linker-Grx3 but did 
 
 
Figure 5. Example of yeast transformation plates. This transformation is pWR104 in the bol2Δ, 
grx3Δ, aft1Δ, and WT backgrounds (left to right) plated on SC-LEU selective media. The plates were 
incubated anaerobically for 48 hours at 30 °C. Abundant growth on transformation plates (top row) and 
no growth on the controls (bottom row) indicates the transformation was successful. 
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show a band for the Grx3-VC positive 
control obtained from Dr. Angela Albetel 
(results not shown). However, western 
blots of pWR103 transformed into aft1∆ 
and bol2Δ probed with α-Grx3 show bands 
with various intensities around 50 kDa that 
are only present in the induced samples 
and indicate expression of VN-linker-Grx3 
protein (MW 48.1 kDa) for all colonies in 
both aft1Δ and bol2Δ (Figure 6A and 6B). 
The strong band in aft1Δ colony 2 and 
bol2Δ colony 4 demonstrates that those 
colonies produced the strongest expression 
of VN-linker-Grx3. The strong band 
located at 28.2 kDa corresponds to the 
native Grx3, which is why the grx3∆ 
negative control lacks that band. The fact 
that these bands are much stronger than 
the VN-linker-Grx3 bands is concerning 
because the TetOFF promoter should have 
 
 
Figure 6. Western blot analysis for VN-linker-Grx3 and Aft1-myc-linker-VC expression in aft1Δ 
and bol2Δ. A) VN-linker-Grx3 in aft1Δ and probed with α-Grx3. VN-linker-Grx3 expressed in all 
colonies. Colony 2 appears to have the strongest expression. B) VN-linker-Grx3 in bol2Δ and probed 
with α-Grx3. VN-linker-Grx3 expressed in all colonies. Colony 4 appears to have the strongest 
expression. C) Aft1-myc-linker-VC in aft1Δ and probed with α-GFP. Aft1-myc-linker-VC was not 
detected. D) Aft1-myc-linker-VC expressed in grx3Δ probed with α-GFP. Aft1-myc-linker-VC was not 
detected. 
 
Red boxes indicate the expected size of the modified proteins. Aft1-myc-linker-VC MW = 90.4 kDa; 
VN-linker-Grx3 MW = 48.1 kDA. rxYFP (28 kDa) is a positive control for α-GFP. grx3Δ and Aft1-
myc are negative controls for α-Grx3 and α-GFP, respectively. n = non-induced (grown w/ doxy in 
western prep). i = induced (grown w/o doxy in western prep). 1-4 denote the 4 individual colonies 




overexpressed the VN-linker-Grx3. 
However, the colonies appear to express 
VN-linker-Grx3 less than native Grx3 
which could potentially interfere with our 
experiments. It is also possible that α-Grx3 
recognizes native Grx3 better than VN-
linker-Grx3 which would also explain the 
observed lower expression. Unfortunately, 
the bol2Δ background displayed an 
unexpected phenotype on nonfermentable 
media (data not shown), which may result 
from unknown spontaneous mutations, 
making this strain untrustworthy for our 
studies. As such, it must be recreated for 
the experiments to proceed. In subsequent 
transformations this background was not 
used. 
Western blotting with α-GFP on 
the pWR104 transformations into aft1Δ 
and grx3Δ indicate that neither 
transformation could be confirmed by this 
technique, or the protein was not being 
expressed in either (Figure 6C and 6D). 
No bands were seen at 90.4 kDa, the size 
of Aft1-myc-linker-VC, for any colonies. 
However, the rxYFP positive control 
provided by Dr. Maxwell Darch was seen 
in both western blots around 28 kDa, 
confirming that the antibodies could 
recognize the YFP protein. The Aft1-myc 
- containing lysate from Debolina Hati 
was used as a negative control since it 
expresses Aft1 with no YFP fragments. 
Although Aft1-myc-linker-VC 
could not be detected in the western blots, 
the transformation plates grew extremely 
well on selective media, which would be 
unlikely if the plasmid is not present in the 
cells. Because of these conflicting results, 
the possibility that the antibodies were not 
recognizing the proteins could not be 
ignored and spot tests were employed as 
an alternative method for testing the 
expression of Aft1-myc-linker-VC (see 
Spot Test Results section). Western blot of 
Aft1-myc-linker-VC expression in aft1Δ + 
pWR103 cells transformed with pWR104 
plasmid and probed with α-c-Myc (Figure 
7A) again failed to show the presence of 
Aft1-myc-linker-VC. However, α-Grx3 on 
the same gel showed the VN-linker-Grx3 
bands in each induced colony (Figure 7B). 
Similarly, western blot testing of VN-
linker-Grx3 expression in aft1Δ + 
pWR104 cells transformed with pWR103 
also verified that VN-linker-Grx3 was 
being expressed in all four induced 
colonies (Figure 7C). For these colonies, 
both α-GFP and α-c-Myc were used 
together in hopes that at least one probe 
will show Aft1-myc-linker-VC expression. 
The VN-linker-Grx3 (48.1 kDa) bands 
were located exactly where expected, but 
the Aft1-myc-linker-VC could still not be 
visualized by probing with either antibody 
(Figure 7D). However, the Aft1-myc 
positive control for α-c-Myc provided by 
Debolina Hati was recognized by the α-c-
Myc antibody. 
The same results were obtained for 
western blotting of myc-Aft2-linker-VC in 
aft2Δ with α-c-Myc (results not shown). 
Again, the lack of a growth phenotype 
during the selection for pWR105 
transformed cells on SC-LEU plates 
conflicted with these results, so a second 
verification method was used (see below). 
Spot Testing: aft1Δ and aft2Δ 
strains have been shown to grow poorly 
when grown in iron limited conditions.13,14 
To test the expression of Aft1-myc-linker-
VC and myc-Aft2-linker-VC in the aft1Δ, 
aft2Δ, and grx3Δ strains, spot testing was 
performed to see phenotypic differences in 
growth on low iron media between parent 
strains, and non-induced and induced 
strains transformed with pWR104, 
pWR105, or pWR103 and pWR104 co-
transformed. Initially, cells transformed 
with the Aft1-myc-linker-VC – containing 
plasmid were plated and cultured in 
selection media under normal iron 
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conditions, then serial dilutions were 
transferred to SC-LEU plates 
supplemented with either 100 μM FAS for 
the high iron condition or with 10 μM of 
the iron chelator BPS for the low iron 
condition. Using this method, no growth 
limitations were observed, regardless of 
iron availability (data not shown). The 
cells may have accumulated enough iron 
during the overnight growth to survive 
growth on the iron depleted plates, and for 
this reason both the beginning liquid 
cultures and the plates were prepared with 
100 μM BPS in subsequent spot tests. In 
this new growth method, Aft1-myc-linker-
VC transformed cells were grown for 24 
hours in 5 ml selection media 
supplemented with 5 μg/ml doxycycline 
and 100 μM BPS, then serial dilutions 
were prepared and plated on selection 
plates supplemented with either 100 μM 
BPS or 100 μM FAS, and with or without 
2 μg/ml doxycycline. Aft1-myc-linker-VC 
in aft1Δ grew in low iron conditions only 
when the plasmid was induced by the 
absence of doxycycline and grew under 
 
 
Figure 7. Western blot analysis for VN-linker-Grx3 and Aft1-myc-linker-VC co-expression in 
aft1Δ. A) Aft1-myc-linker-VC in VN-linker-Grx3(aft1Δ) probed with α-c-Myc. Aft1-myc-linker-VC 
was not detected. B) Aft1-myc-linker-VC in VN-linker-Grx3(aft1Δ) probed with α-Grx3. VN-linker-
Grx3 expressed in all colonies. C) VN-linker-Grx3 in Aft1-myc-linker-VC(aft1Δ) probed with α-Grx3. 
VN-linker-Grx3 expressed in all colonies. D) VN-linker-Grx3 in Aft1-myc-linker-VC(aft1Δ) probed 
with α-c-Myc and α-GFP. Aft1-myc-linker-VC was not detected. VN-linker-Grx3 expressed in all 
colonies. 
 
Red boxes indicate the expected size of the modified proteins. Aft1-myc-linker-VC MW = 90.4 kDa; 
VN-linker-Grx3 MW = 48.1 kDA; Aft1-myc (79.95 kDA) is a positive control for α-c-Myc and α-
Grx3. n = non-induced (grown w/ doxy in western prep). i = induced (grown w/o doxy in western prep). 






 high iron conditions regardless of whether 
the plasmid was induced or not (Figure 
8A-D). The aft1Δ and grx3Δ control 
strains grown under the same conditions 
and plated on synthetic complete (SC) 
media supplemented with and without 2 
μg/ml doxycycline and 100 μM BPS 
exhibit the previously reported growth 
phenotypes (Figure 8E).13-17 Additionally, 
the aft1Δ and grx3Δ background strains 
grown on SC-LEU media supplemented 
with and without 2 μg/ml doxycycline and 
100 μM BPS did not grow, reconfirming 
that the presence of pWR104 plasmid 
carrying the selection gene is required for 
these cells to survive (Figure 8F). 
Aft1-myc-linker-VC in grx3Δ 
grew in low iron conditions only when the 
plasmid was induced by the absence of 
doxycycline and grew under high iron 
 
 
Figure 8. Spot test results for the transformation and expression of Aft1-myc-VC in aft1Δ. Serial 
dilutions of 4 individual colonies of Aft1-myc-VC in aft1Δ  Batch 1 (from when western blotting 
initially showed no protein expression) were plated on: A) SC-LEU with 100 µM BPS + 2 µg/mL doxy 
(left) or just 100 µM BPS (right) and incubated aerobically at 30 °C for 5 days; B) SC-LEU with 100 
µM FAS + 1 µg/mL doxy (left) or just 100 µM FAS (right) and incubated aerobically at 30 °C for 3 
days. Serial dilutions of 4 individual colonies of Aft1-myc-VC in aft1Δ Batch 2 were plated on: C) SC-
LEU with 100µM BPS + 2 µg/mL doxy (left) or just 100 µM BPS (right) and incubated aerobically at 
30 °C for 5 days; D) SC-LEU with 100 µM FAS + 1 µg/mL doxy (left) or just 100 µM FAS (right) and 
incubated aerobically at 30 °C for 3 days. E) Serial dilutions of aft1Δ and grx3Δ background strains 
grown for 3 days on SC as a positive control. F) Serial dilutions of aft1Δ and grx3Δ background strains 
incubated for 5 days on SC-LEU as a negative control. 
 
BPS=bathophenathrolinesulfonic acid; FAS=ferrous ammonium sulfate; doxy=doxycycline; 1-4 
indicate that 4 individual colonies were screened. 
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conditions regardless of whether the 
plasmid was induced or not (Figure 9A-
D). This result is somewhat unexpected 
because Grx3 is supposed to be fully 
redundant with Grx4,15-17 so growth 
deficiency under low iron conditions was 
not expected (see Figure 8E). Taken 
together, these results indicate that Aft1-
myc-linker-VC is expressed in aft1Δ and 
possibly grx3Δ backgrounds. 
Spot tests of VN-linker-Grx3 co-
transformed with Aft1-myc-linker-VC in 
aft1Δ and grown as described above 
(Figure 10) exhibited growth in SC-LEU/-
URA low iron conditions when the 
plasmid is induced, indicating that the 
Aft1-myc-linker-VC plasmid is also being 
expressed (Figure 10A and 10B). Western 
blot results confirmed expression of Grx3-
linker-VC previously (Figure 7B and 7C). 
As expected, under high iron conditions, 
the cells grew independent of plasmid 
induction. Because the cells were able to 
grow on SC-LEU/-URA media, both 
plasmids must be expressed as they each 
contain a gene that enables the production 
of one of those amino acids. Additionally, 
the tagged proteins are being produced 
because the limited growth phenotype 
expected for aft1Δ cells is recovered in 
these transformations.  
 
 
Figure 9. Spot test results for the transformation and expression of Aft1-myc-VC in grx3Δ. Serial 
dilutions of 4 individual colonies of Aft1-myc-VC in grx3Δ Batch 1 (from when western blotting 
initially showed no protein expression) were plated on: A) SC-LEU with 100 µM BPS + 2 µg/mL doxy 
(left) or just 100µM BPS (right) and incubated aerobically at 30 °C for 5 days; B) SC-LEU with 100 
µM FAS + 1 µg/mL doxy (left) or just 100 µM FAS (right) and incubated aerobically at 30 °C for 3 
days. Serial dilutions of 4 individual colonies of Aft1-myc-VC in grx3Δ Batch 2 were plated on: C) 
SC-LEU with 100 µM BPS + 2 µg/mL doxy (left) or just 100 µM BPS (right) and incubated aerobically 
at 30 °C for 5 days: D) SC-LEU with 100 µM FAS + 1 µg/mL doxy (left) or just 100 µM FAS (right) 
and incubated aerobically at 30 °C for 3 days. 
 
BPS=bathophenathrolinesulfonic acid; FAS=ferrous ammonium sulfate; doxy=doxycycline; 1-4 





Spotting of myc-Aft2-linker-VC - 
containing plasmid transformed in aft2Δ 
showed better growth on induced colonies 
than non-induced colonies in low iron 
conditions, indicating that the myc-Aft2-
linker-VC was expressed (Figure 11A). 
The same cells showed no growth 
impairment when grown on plates with 
high iron and normal iron conditions, and 
no significant difference was observed 
between these two conditions (Figure 11B 
and 11C). Although myc-Aft2-linker-VC 
in grx3Δ grew well for the normal and 
high iron conditions (Figures 11E and 
11F), it appeared to grow better under low 
iron conditions when the protein was not 
expressed (Figure 11D). The non-
transformed aft2Δ and grx3Δ control cells 
grew well in all conditions on SC media, 
though they took longer to grow in low 
iron (Figure 11G), which was the expected 
phenotype for aft2Δ. No growth was 
observed for these control strains when 
grown on SC-LEU, since they lack the 
plasmid encoding the leucine production 
gene (Figure 11H). Because the presence 
and absence of doxy in the controls did not 
affect their growth but appeared to affect 
the growth of transformed cells, the spot 
test for myc-Aft2-linker-VC in grx3Δ will 




Figure 10. Spot test results for the transformation and co-expression of Aft1-myc-linker-VC and 
VN-linker-Grx3 in aft1Δ. Serial dilutions of 4 individual colonies of Aft1-myc-VC transformed into 
VN-linker-Grx3(aft1Δ) cells were plated on: A) SC-LEU/-URA supplemented with 100 µM BPS + 2 
µg/mL doxy (left) or just 100 µM BPS (right) and incubated aerobically at 30 °C for 5 days; B) SC-
LEU/-URA supplemented with 100 µM FAS + 1 µg/mL doxy (left) or just 100 µM FAS (right) and 
incubated aerobically at 30 °C for 3 days.  Serial dilutions of 4 individual colonies of VN-linker-Grx3 
transformed into Aft1-myc-VC(aft1Δ) cells were plated on: C) SC-LEU/-URA supplemented with 100 
µM BPS + 2 µg/mL doxy (left) or just 100 µM BPS (right) and incubated aerobically at 30 °C for 5 
days; D) SC-LEU/-URA supplemented with 100 µM FAS + 1 µg/mL doxy (left) or just 100 µM FAS 
(right) and incubated aerobically at 30 °C for 3 days. 
 
BPS=bathophenathrolinesulfonic acid; FAS=ferrous ammonium sulfate; doxy=doxycycline; 1-4 






In this work, we present our efforts 
to investigate whether Bol2 is required for 
the interaction between Grx3/4 and Aft1/2 
during in vivo iron regulation in yeast S. 
cerevisiae using BiFC studies. To 
adequately accomplish our research goal, 
Grx3/4 and Aft1/2 were tagged with either 
the N-terminal half (VN) or C-terminal 
half (VC) of the yellow fluorescence 
protein Venus, respectively. A linker was 
 
 
Figure 11. Spot test results for the transformation and expression of myc-Aft2-linker-VC and 
aft1Δ and grx3Δ. Serial dilutions of 4 individual colonies of myc-Aft2-linker-VC transformed into 
aft2Δ cells were plated on: A) SC-LEU/-URA supplemented with 100 µM BPS and 2 µg/mL doxy (left) 
or just 100 µM BPS (right), and incubated aerobically at 30 °C for 5 days; B) SC-LEU/-URA 
supplemented with 1 µg/mL doxy (left) or just SC-LEU (right) and incubated aerobically at 30 °C for 2 
days; C) SC-LEU/-URA supplemented with 100 µM FAS + 1 µg/mL doxy (left) or just 100 µM FAS 
(right) and incubated aerobically at 30 °C for 2 days. Serial dilutions of 4 individual colonies of myc-
Aft2-linker-VC transformed into grx3Δ cells were plated on: D) SC-LEU/-URA supplemented with 100 
µM BPS + 2 µg/mL doxy (left) or just 100 µM BPS (right) and incubated aerobically at 30 °C for 5 
days; E) SC-LEU/-URA supplemented with 1 µg/mL doxy (left) or just SC-LEU (right) and incubated 
aerobically at 30 °C for 2 days; F) SC-LEU/-URA supplemented with 100 µM FAS + 1 µg/mL doxy 
(left) or just 100 µM FAS (right) and incubated aerobically at 30 °C for 2 days. G) The aft2Δ and grx3Δ 
background strains grown on SC with and without doxy and BPS or FAS for 3 days as a positive 
control. H) The aft2Δ and grx3Δ background strains grown on SC-LEU with and without doxy and 
BPS or FAS for 5 days as a negative control. 
 
BPS=bathophenathrolinesulfonic acid; FAS=ferrous ammonium sulfate; doxy=doxycycline; 1-4 





inserted between each protein and its 
respective tag to allow for proper folding. 
For each possible combination of tagged 
proteins, a variety of yeast strains were  
tested, including bol2∆, grx3∆, aft1∆, and 
aft2∆ (Table 7). So far, VN-linker-Grx3 in 
aft1∆, Aft1-myc-linker-VC in 
grx3∆/aft1∆, myc-Aft2-linker-VC in 
aft2Δ, and VN-linker-Grx3/Aft1-myc-
linker-VC in aft1Δ have been transformed 
and the expression of the tagged proteins 
has been verified. Spot testing of myc-
Aft2-VC in grx3Δ needs to be repeated as 
the results were inconclusive. These 
strains will be useful primarily in testing 
the interaction between Grx3 and Aft1 
through fluorescence microscopy.  
 
Before experiments can proceed, 
additional strains need to be created and 
the bol2Δ background needs to be 
recreated. To test Grx3 and Aft1 
interaction, VN-linker-Grx3 (grx3Δ), VN-
linker-Grx3 (bol2Δ), Aft1-myc-linker-VC 
(bol2Δ), VN-linker-Grx3/Aft1-myc-linker-
VC (grx3∆), and VN-linker-Grx3/Aft1-
myc-linker-VC (bol2Δ) still need to be 
produced. Each of the plasmids has been 
created, so the remaining steps are to redo 
the transformation and verify if it was 
successful using western blotting and spot 
testing. Studying the interaction between 
Grx3 and Aft2 will require cloning and 
expression of VN-linker-Grx3 and myc-
Aft1-linker-VC separately (for negative 
controls) or together in grx3∆, aft2∆, and 
bol2∆. Although only myc-Aft2-linker-VC 
(aft2∆) has been successfully transformed, 
both plasmids have been produced. The 
co-transformations must be attempted and 
verified. Then we will be ready to test the 
interaction. Testing the Grx4-Aft1 and 
Grx4-Aft2 interactions will require the 
same set up in terms of the backgrounds 
required with a native protein knockout for 
each protein to be tested. Again, the 
plasmids are created and only need to be 
transformed into the background strains 
and verified for the experiments to 
commence. See Table 7 for a summary of 
what yeast strains have been produced and 
still need to be produced. 
Once these yeast strains have been 
produced, BiFC studies will be carried out 
by monitoring the presence/absence of 
fluorescence using an IX81 Automated 
Inverted microscope (Olympus). Each 
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protein combination mentioned in Table 7 
will be grown under varying iron 
conditions (low, normal, high) and 
visualized using the microscope. It is 
expected that fluorescence from Grx3/4 
interaction with Aft1/2 will be observed in 
all backgrounds, other than bol2∆. This 
would demonstrate that Bol2 is required 
for the interaction between these two 
protein types in vivo, thus confirming the 
in vitro data.20 Additionally, we will be 
able to visualize which cellular 
compartment the Aft1/2-Grx3/4 
interaction is taking place in to further 
elucidate the mechanism by which the 
interaction results in turning off iron 
regulation genes. 
Validating the S. cerevisiae iron 
regulation model in which [2Fe-2S]-
Grx3/4-Bol2 complex interacts with 
Aft1/2, leading to their dimerization and 
subsequently inactivating the iron regulon, 
would aid in understanding human 
diseases and conditions. Glrx3 and BolA2, 
the human homologs, may interact by a 
similar mechanism, so understanding the 
interaction and its function in a simpler 
organism, like yeast, will contribute to our 
understanding of how these two human 
homologs function. This could lead to a 
greater understanding of human iron 
regulation and the roles of Glrx3 and 
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